IDT vs Ziff Davis
IDT and ZD side by side. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IDT and ZD compare
IDT is the larger company, worth 1.2 times as much as Ziff Davis ($2.1B against $1.8B).
On earnings, Ziff Davis is cheaper: it trades at 3.0× trailing earnings, against 24.0× for IDT.
Ziff Davis grew revenue faster over the last twelve months (10.4% versus 5.4% for IDT).
Ziff Davis keeps more of each dollar of sales as profit, with a net margin of 43.5% compared with 6.7% at IDT.
IDT pays a dividend yielding 0.32%; Ziff Davis does not pay one.
IDT scores higher on the StockData Score (18 against 14 for Ziff Davis), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IDT | ZD |
|---|---|---|
| Size and price | ||
| Market cap | $2.1B | $1.8B |
| Share price | $83.09 | $51.49 |
| Change, 1 year | 58.9% | 60.8% |
| Change, 5 years | 33.1% | −57.5% |
| Beta (5Y) | 0.85 | 1.13 |
| Employees | 1,971 | 3,900 |
| StockData Score | ||
| Total score | 18 (better) | 14 |
| Valuation score | 0 | 6 (better) |
| Growth score | 4 (better) | 2 |
| Performance score | 5 (better) | 3 |
| Health score | 6 (better) | 3 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 24.0× | 3.0× (better) |
| P/S | 1.6× | 1.2× (better) |
| P/B | 5.5× | 0.8× (better) |
| EV/EBITDA | 13.1× | 4.6× (better) |
| P/FCF | 30.4× | 16.3× (better) |
| PEG | 0.80 | – |
| FCF yield | 3.3% | 6.1% (better) |
| Fair value | $50.42 | $79.51 |
| Margin of safety | −64.8% | 35.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.4% | 10.4% (better) |
| Revenue growth, 5Y average | −2.2% | 4.6% (better) |
| Net income growth (TTM) | 13.9% | 457% (better) |
| EPS growth (TTM) | 15.0% | 548% (better) |
| EPS growth, 5Y average | −1.3% (better) | −18.4% |
| Profitability | ||
| Gross margin | 38.3% | 84.9% (better) |
| Operating margin | 9.3% (better) | 4.8% |
| Net margin | 6.7% | 43.5% (better) |
| FCF margin | 5.2% | 7.6% (better) |
| Return on equity | 25.4% | 31.5% (better) |
| Return on invested capital | 75.4% (better) | 2.9% |
| Financial health | ||
| Debt / equity | 0.00 | 0.41 (better) |
| Net debt / EBITDA | – | −2.01 |
| Current ratio | 1.86 | 2.35 (better) |
| Altman Z-score | 6.61 (better) | 2.12 |
| Piotroski F-score | 6 | 6 |
| Dividends and buybacks | ||
| Dividend yield | 0.32% | – |
| Payout ratio | 7.5% | – |
| Years of dividend growth | 2 | – |
| Buyback yield | – | 18.4% |
| Shareholder yield | 0.32% | 18.4% (better) |
| Ownership | ||
| Held by institutions | 56.5% | 120% |
| Held by insiders | 17.6% | 9.6% |
| Insider net buying, 12 months | −$7.7M | −$2.1M (better) |
| Superinvestors holding | – | 1 |
| Short interest, % of float | 4.9% | 14.9% |
Go deeper
- IDT stock overview
- IDT income statement
- IDT valuation and score
- ZD stock overview
- ZD income statement
- ZD valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.